The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis
NCT ID: NCT06881173
Last Updated: 2025-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
112 participants
INTERVENTIONAL
2022-06-14
2025-06-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome.
NCT04111341
A Registry Study of Shuxuening Injection Used in Hospitals in China
NCT01752946
Traditional Chinese Medicine on Gut Microbiota and Allergic Diseases
NCT03033290
Efficacy Study of Acupoint Sticking in Summer to Treat Asthma
NCT02580942
Evaluation of Laser Acupuncture on Health Promotion of Sub-health People
NCT04325945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Have taken Bu Zhong Yi Qi Tang
Bu Zhong Yi Qi Tang
The experimental group took 15g of Buzhong Yiqi Decoction concentrated powder, 3 times a day, 1 packet each time.
control group
Have taken caramel dyed starch placebo
caramel dyed starch placebo
The control group took 15 grams of caramel dyed starch placebo, 1 pack at a time, 3 times a day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bu Zhong Yi Qi Tang
The experimental group took 15g of Buzhong Yiqi Decoction concentrated powder, 3 times a day, 1 packet each time.
caramel dyed starch placebo
The control group took 15 grams of caramel dyed starch placebo, 1 pack at a time, 3 times a day.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Western medicine prescriptions only take oral Mestinon (Pyrido stigmine Bromide)
* Patients over 20 years old
* Can understand and understand Those who can speak Mandarin or Taiwanese
* those with a clear state of consciousness and no diagnosis of mental illness
* patients and their families who are willing to receive precise integrated treatment of traditional Chinese and Western medicine.
Exclusion Criteria
* Allergy symptoms to traditional Chinese medicine, such as skin itching and redness
* Patients with malignant tumors
* Patients currently undergoing radiotherapy and chemotherapy
* Pregnant
* Cardiac rhythm device implementer
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cheng, yu-ting
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cheng, yu-ting
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ju-Han Liu
Role: STUDY_CHAIR
project leader
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20220305R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.